The Valley Desk

Clinical trial reportClinical therapeuticsPublished

Bilateral Effect of OC-01 (Varenicline Solution) Nasal Spray for Treatment of Signs and Symptoms in Individuals with Mild, Moderate, and Severe Dry Eye Disease

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Salus University, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
Clinical therapeutics
Published
Subject terms
Humans; Dry Eye Syndromes; Nasal Sprays; Varenicline; Dry Eye Disease; Pharmacologic Neuroactivator; Trigeminal Parasympathetic Pathway; Oc-01 (Varenicline Solution) Nasal Spray
PubMed ID
36763994
Added to directory
Source checked

Report a correction or request removal